[ET Net News Agency, 12 September 2025] INNOCARE (09969) rose 9.6% to HK$18.43.
It hits an intra-day high of HK$18.59, breaking above the 50-D SMA of HK$17.603, and an intra-day low of HK$16.9. The total shares traded was 9.8 million, with a value of HK$173.15m. The active buy/sell ratio is 64:36, with net buying turnover of HK$45.77m. CITIC SEC BRO accounts for greatest net responsive buying turnover of HK$5.94m, with volume weighted average price of HK$18.27. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$6.54m, with volume weighted average price of HK$17.785.
Basic Information| Nominal | 18.430 | % Chg | +9.57% |
| High | 18.590 | Low | 16.900 |
| Shares Tr | 9.8m | Turnover | 173.15m |
| 10-D SMA | 17.621 | %H.V | 57.003 |
| 20-D SMA | 17.955 | VWAP | 17.663 |
| 50-D SMA | 17.603 | RSI14 | 55.085 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 64:36, with net buying turnover of HK$45.77m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOCARE (09969) | 18.43 | +9.57 |
| SINO BIOPHARM (01177) | 8.67 | +2.73 |
| 3SBIO (01530) | 32.22 | +0.81 |
| KEYMED BIO-B (02162) | 74.65 | -1.84 |
| WUXI XDC (02268) | 67.00 | +4.36 |
| ASCENTAGE-B (06855) | 79.60 | +2.64 |
| SKB BIO-B (06990) | 508.00 | +3.42 |
| ZAI LAB (09688) | 26.14 | +7.84 |
| AKESO (09926) | 135.40 | +6.03 |
| REMEGEN (09995) | 109.60 | -1.88 |
(ed)
Nominal 